Veterinary Medicines

Vasotop 0,625 mg Tabletten

Authorised
  • Ramipril
Download as PDF

Product identification

Medicine name:
Vasotop 0,625 mg Tabletten
Vasotop P 0,625mg Tabletten
Active substance:
  • Ramipril
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ramipril
    0.63
    milligram(s)
    /
    1.00
    Piece
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • Carton box containing six 15 mL HD polyethylene containers containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.
  • Carton box containing one 15 mL HD polyethylene container containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.
  • Carton box containing three 15 mL HD polyethylene containers containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • BVL
Authorisation number:
  • 400183.03.00
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0245/001
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Norway
  • Spain
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."